Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035226 | SCV000058871 | likely benign | not specified | 2008-03-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000397998 | SCV000392296 | likely benign | Weill-Marchesani syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000303570 | SCV000392297 | likely benign | Geleophysic dysplasia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000355990 | SCV000392298 | likely benign | Acromicric dysplasia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000263353 | SCV000392299 | likely benign | Ectopia lentis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000297465 | SCV000392300 | likely benign | Marfan syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000354690 | SCV000392301 | likely benign | MASS syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000276436 | SCV000392302 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000330003 | SCV000392303 | likely benign | Stiff skin syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000589101 | SCV000520906 | likely benign | not provided | 2021-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589101 | SCV000695559 | benign | not provided | 2016-05-02 | criteria provided, single submitter | clinical testing | Variant summary: The c.5442C>T (p.Asn1814=) in FBN1 gene is a synonymous change that involves a non-conserved nucleotide. 5/5 in silico programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.00014 (18/121254 chrs tested), which exceeds the maximal expected frequency of a pathogenic allele (0.000125) in this gene. The variant of interest was cited as Likely Benign by reputable database/clinical laboratory. Taking together, the variant was classified as Benign. |
Color Diagnostics, |
RCV000276436 | SCV000913674 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-07-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001468352 | SCV001672395 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-01-03 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000276436 | SCV002041998 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-03-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000276436 | SCV002652267 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2017-12-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000297465 | SCV004814658 | likely benign | Marfan syndrome | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004737172 | SCV005353148 | likely benign | FBN1-related disorder | 2024-07-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |